HILDEN, Germany and GERMANTOWN, Maryland, October 2, 2017 /PRNewswire/ --

QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its manufacturing and supply chain for consumables and other products for forensic and human identity testing has been certified by Bureau Veritas, a leading inspection agency, as meeting the latest international standards for products used in forensic testing. QIAGEN is a global leader in molecular testing solutions for human identification and has actively supported the development of global forensic standards. In pursuit of continuous improvement, QIAGEN has a long history of working with experts in forensic sciences and law enforcement to upgrade requirements designed to minimize the contamination of samples and to ensure the highest level of accuracy in DNA fingerprinting.

The Bureau Veritas certification represents a seal of approval that QIAGEN complies with the latest standard, known as ISO18385:2016, adopted to prevent contamination of products for DNA casework and reference databases. The requirements cover the manufacturing of products used in the collection, storage and analysis of human DNA during forensic testing, including sampling kits such as swabs, containers and packaging, and consumables used in the analysis of DNA samples by forensic laboratories.

Click here [http://corporate.qiagen.com/newsroom/press-releases/2017/2017-10-02-HID-ISO-Certification?sc_lang=en ] for the full press release http://corporate.qiagen.com/newsroom/press-releases/2017/2017-10-02-HID-ISO-Certification? sc_lang=en [https://urldefense.proofpoint.com/v2/url?u=http-3A__corporate.qiagen.com_newsroom_press-2Dreleases_2017_2017-2D10-2D02-2DHID-2DISO-2DCertification-3Fsc-5Flang-3Den&d=DwMGaQ&c=qwStF0e4-YFyvjCeML3ehA&r=ooUNN5xnz7ArPD5-0mcOWB6L8hlzM7cOxW_ACjFAmlY&m=abdjNjI0yN0xU1gLUte4byCq-TCjrzddIetlyskXO9s&s=zR_cpB2uNe1EPSWQQUlBfZqAR0pvi3wFMkbaFhy5Cr4&e= ] 


        

        Contacts: 

        QIAGEN 

        Investor Relations           
        John Gilardi 
        +49-2103-29-11711     
        e-mail: ir@QIAGEN.com               

        Public Relations 
        Dr. Thomas Theuringer 
        +49-2103-29-11826 
        e-mail: pr@QIAGEN.com

 

SOURCE Qiagen N.V.